The bill, known as the Jeff, Dave, and Angie Patient Right to Try Act, proposes the enactment of section 3792.08 of the Revised Code, which outlines the conditions under which prescribers can issue prescriptions for drugs, including off-label uses, provided they obtain informed consent from the patient or their personal representative. The bill defines key terms such as "health-related licensing board," "hospital," "in-house prescriber," and "off-label use," and establishes the responsibilities of prescribers, pharmacists, and healthcare facilities in the prescribing and dispensing process. It emphasizes the importance of informed consent, requiring prescribers to communicate essential information about the drug, including risks, benefits, and any financial conflicts of interest.

Additionally, the bill provides protections for healthcare professionals by stating that actions taken under this section will not be considered unlawful or unprofessional conduct, except in cases of recklessness or gross negligence. It also affirms the right to free speech for healthcare professionals regarding their opinions on drug safety and efficacy, while clarifying that existing laws concerning controlled substances, certain drugs, and abortifacients remain unaffected. Overall, the legislation aims to enhance patient access to potentially beneficial treatments while ensuring informed decision-making and protecting healthcare providers from undue liability.